Cargando…
Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer: a single-centre cohort study
BACKGROUND: Chemoradiation with capecitabine followed by surgery is standard care for locally advanced rectal cancer (LARC). Severe diarrhea is considered a dose-limiting toxicity of adding capecitabine to radiation therapy. The aim of this study was to describe the risk factors and the impact of bo...
Autores principales: | van Rees, J. M., Hartman, W., Nuyttens, J. J. M. E., Oomen-de Hoop, E., van Vugt, J. L. A., Rothbarth, J., Verhoef, C., van Meerten, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336279/ https://www.ncbi.nlm.nih.gov/pubmed/34348673 http://dx.doi.org/10.1186/s12876-021-01886-3 |
Ejemplares similares
-
Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma
por: Hagemans, J. A. W., et al.
Publicado: (2019) -
Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer
por: van Rees, Jan M, et al.
Publicado: (2021) -
Preoperative Chemoradiation in Locally Advanced Rectal Cancer: A Comparison of Bolus 5-Fluorouracil/Leucovorin and Capecitabine
por: Yoney, Adnan, et al.
Publicado: (2014) -
Response to chemotherapy in patients with recurrent rectal cancer in previously irradiated area
por: Alberda, W. J., et al.
Publicado: (2015) -
Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2)
por: Gollins, S W, et al.
Publicado: (2009)